Categories: Bulk Drug

Dr Reddy’s, AstraZeneca in pact for diabetes drug

Hyderabad, June 01, 2015

Pharma major Dr Reddy’s Laboratories and AstraZeneca Pharma India Ltd have entered into a distribution agreement for Riax, a new brand of saxagliptin and Riax-M, which is used in the type-II diabetes treatment.

The drugs are trademarks of the AstraZeneca group which already has two brands under Onglyza and Kombiglyze for saxagliptin and in fixed dose combination with metformin respectively, promoted and distributed in the domestic market. “We are pleased to partner with AstraZeneca in launching saxagliptin and its combination with metformin, an important addition to our diabetes franchise.

“This will expand access to innovative medicines to vast number of diabetes patients in India,’’ Alok Sonig, Senior Vic- President and Head of India Business, Dr Reddy’s, said in a release issued here on Friday.

Dr Reddy’s Laboratories Ltd will be distributing Riax and Riax M in India.

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago